[go: up one dir, main page]

FI900035A7 - Tiazolfoereningar, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska blandningar. - Google Patents

Tiazolfoereningar, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska blandningar. Download PDF

Info

Publication number
FI900035A7
FI900035A7 FI900035A FI900035A FI900035A7 FI 900035 A7 FI900035 A7 FI 900035A7 FI 900035 A FI900035 A FI 900035A FI 900035 A FI900035 A FI 900035A FI 900035 A7 FI900035 A7 FI 900035A7
Authority
FI
Finland
Prior art keywords
thiazolfoereningar
farmaceutiska
blandningar
foerfarande foer
deras framstaellning
Prior art date
Application number
FI900035A
Other languages
English (en)
Other versions
FI900035A0 (fi
Inventor
Hisashi Takasugi
Shigetaka Nishino
Akito Tanaka
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB898900191A external-priority patent/GB8900191D0/en
Priority claimed from GB898906575A external-priority patent/GB8906575D0/en
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of FI900035A0 publication Critical patent/FI900035A0/fi
Publication of FI900035A7 publication Critical patent/FI900035A7/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/44—Acylated amino or imino radicals
    • C07D277/48—Acylated amino or imino radicals by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof, e.g. carbonylguanidines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
FI900035A 1989-01-05 1990-01-04 Tiazolfoereningar, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska blandningar. FI900035A7 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898900191A GB8900191D0 (en) 1989-01-05 1989-01-05 Thiazole compounds,processes for the preparation thereof and pharmaceutical composition comprising the same
GB898906575A GB8906575D0 (en) 1989-03-22 1989-03-22 Thiazole compounds,processes for the preparation thereof and pharmaceutical compositions comprising the same

Publications (2)

Publication Number Publication Date
FI900035A0 FI900035A0 (fi) 1990-01-04
FI900035A7 true FI900035A7 (fi) 1990-07-06

Family

ID=26294803

Family Applications (1)

Application Number Title Priority Date Filing Date
FI900035A FI900035A7 (fi) 1989-01-05 1990-01-04 Tiazolfoereningar, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska blandningar.

Country Status (11)

Country Link
EP (1) EP0377457A1 (fi)
JP (1) JP3003148B2 (fi)
KR (1) KR900011765A (fi)
CN (1) CN1043936A (fi)
AU (1) AU631169B2 (fi)
CA (1) CA2007133A1 (fi)
FI (1) FI900035A7 (fi)
HU (1) HU205922B (fi)
IL (1) IL92939A0 (fi)
NO (1) NO900032L (fi)
PT (1) PT92786B (fi)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0372125A1 (en) * 1988-11-08 1990-06-13 Akzo N.V. Oxazole and thiazole derivatives
DE69132293D1 (de) * 1991-03-07 2000-08-10 Hisamitsu Pharmaceutical Co Diphenylthiazolderivate mit antiinflammatorischer aktivität
PT626968E (pt) * 1992-02-13 2002-03-28 Merrell Pharma Inc Derivados de piperidinilo tiaciclicos
CA2101311A1 (en) * 1992-07-31 1994-02-01 Neelakantan Balasubramanian Adenosine re-uptake inhibiting derivatives of diphenyl oxazoles, thiazoles and imidazoles
TWI292316B (en) * 1999-10-11 2008-01-11 Sod Conseils Rech Applic Pharmaceutical composition of thiazole derivatives intended to inhibit mao and/or lipidic peroxidation and/or to act as modulators of sodium channels and the use thereof
US20020183316A1 (en) * 2000-10-27 2002-12-05 Kevin Pan Amidoalkyl-piperidine and amidoalkyl-piperazine derivatives useful for the treatment of nervous system disorders
AR038966A1 (es) * 2002-03-18 2005-02-02 Solvay Pharm Bv Derivados de tiazol que tienen actividad antagonista, agonista o agonista parcial de cb1
GB0216700D0 (en) 2002-07-18 2002-08-28 Astrazeneca Ab Process
IL166510A0 (en) 2002-08-09 2006-01-15 Nps Pharma Inc 1,2,4"oxadiazole as modulators of metabotropic glutamate receptor-5
AR041508A1 (es) * 2002-08-09 2005-05-18 Astra Ab Compuestos con actividad en los receptores de glutamato metabotropicos
US7074809B2 (en) 2002-08-09 2006-07-11 Astrazeneca Ab Compounds
US20040198800A1 (en) * 2002-12-19 2004-10-07 Geoffrey Allan Lipoxygenase inhibitors as hypolipidemic and anti-hypertensive agents
GB0230087D0 (en) * 2002-12-24 2003-01-29 Astrazeneca Ab Therapeutic agents
GB0302673D0 (en) 2003-02-06 2003-03-12 Astrazeneca Ab Pharmaceutical formulations
GB0302672D0 (en) * 2003-02-06 2003-03-12 Astrazeneca Ab Pharmaceutical formulations
JP2006182648A (ja) * 2003-04-08 2006-07-13 Dai Ichi Seiyaku Co Ltd ７員複素環誘導体
WO2004094407A1 (ja) * 2003-04-21 2004-11-04 Daiichi Pharmaceutical Co. Ltd. ５員複素環誘導体
SA04250288B1 (ar) * 2003-09-19 2008-07-19 سولفاي فارماسوتيكالز بي . في مشتقات ثيازول thiazole كمعدلات لمستقبل المكونات الكيميائية للقنب cannabinoid
CA2543338A1 (en) * 2003-10-24 2005-05-06 Solvay Pharmaceuticals Gmbh Novel medical uses of compounds showing cb1-antagonistic activity and combination treatment involving said compounds
WO2006045799A2 (en) 2004-10-25 2006-05-04 Solvay Pharmaceuticals Gmbh Pharmaceutical compositions comprising cb1 cannabinoid receptor antagonists and potassium channel openers for the treatment of diabetes mellitus type i, obesity and related conditions
DE102009038123A1 (de) 2009-08-17 2011-02-24 Aicuris Gmbh & Co. Kg Substituierte (Thiazolyl-carbonyl)imidazolidinone und ihre Verwendung
PE20190806A1 (es) * 2016-10-12 2019-06-10 Res Triangle Inst Agonistas heterociclicos del receptor de apelina (apj) y usos de los mismos

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1496787A (en) * 1974-03-12 1978-01-05 Smith Kline French Lab Heteroalkylthioalkyl amidine derivatives
US4168315A (en) 1977-09-28 1979-09-18 The Upjohn Company Dianisyl thiazole compound, compositions and method of antithrombotic treatment
AU539801B2 (en) * 1980-10-14 1984-10-18 Pfizer Inc. Intermediates in the preparation of 2-guanidino-4- heteroarylthiazoles
DE3413755A1 (de) * 1984-04-12 1985-10-24 Basf Ag, 6700 Ludwigshafen Thiazolylharnstoffe, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung unerwuenschten pflanzenwuchses
DE3621775A1 (de) * 1986-03-13 1988-01-07 Thomae Gmbh Dr K Neue substituierte thiazole und oxazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
GB8714789D0 (en) * 1987-06-24 1987-07-29 Lundbeck & Co As H Heterocyclic compounds

Also Published As

Publication number Publication date
FI900035A0 (fi) 1990-01-04
HUT54129A (en) 1991-01-28
JPH0327370A (ja) 1991-02-05
AU4768790A (en) 1990-07-12
JP3003148B2 (ja) 2000-01-24
HU205922B (en) 1992-07-28
AU631169B2 (en) 1992-11-19
HU900041D0 (en) 1990-03-28
CN1043936A (zh) 1990-07-18
EP0377457A1 (en) 1990-07-11
IL92939A0 (en) 1990-09-17
NO900032L (no) 1990-07-06
PT92786B (pt) 1996-01-31
NO900032D0 (no) 1990-01-04
KR900011765A (ko) 1990-08-02
CA2007133A1 (en) 1990-07-05
PT92786A (pt) 1990-07-31

Similar Documents

Publication Publication Date Title
FI922037L (fi) Uppsvaellbart, brandhaerdigt och elledande bestrykningsmaterial.
FI903845A0 (fi) Renininhibitorer, foerfarande foer deras framstaellning och deras anvaendning i laekemedel.
FI905754L (fi) Biologiskt nedbrytbara, vattenloesliga ympkopolymerer, kompositioner innehaollande dylika kopolymerer, och foerfaranden foer anvaendning av dylika kopolymerer.
FI921867L (fi) Termiskt bundna vaevnader, fram- staellning och anvaendning.
FI914144A0 (fi) Syrabestaendiga betongprodukter, speciellt svavelbetongroer och deras framstaellningfoerfarande.
FI905700A7 (fi) Heterocykliska foereningar, deras framstaellning och dessa innehaollande laekemedel.
FI882249L (fi) Tvaerbundet, vattenoloesligt glukosisomeras och foerfarande foer framstaellning daerav.
FI900035A7 (fi) Tiazolfoereningar, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska blandningar.
FI906108L (fi) Serotoninantagonister, deras framstaellning och dessa innehaollande laekemedel.
FI915404A0 (fi) Endotermiska drivgaser, kompositioner och tillaempningar.
FI905943L (fi) Isotinderivat, deras framstaellning och anvaendning.
FI903970L (fi) Insekticida, akaricida och nematicida arylpyrrolaemnen och foerfaranden foer deras framstaellning.
FI891061A7 (fi) Kondenserade kinolinfoereningar, kondenserade akridinfoereningar, foerfarande foer framstaellning daerav och karsinostatiska kompositioner innehaollande desamma.
FI906044L (fi) Buffrad tvaettmedelskomposition oloesliggoerande komposition, testmedel och anvaendningsfoerfarande.
FI904823A0 (fi) Karboxylsyraestrar, naemnda karboxylsyraestrar innehaollande flytande kompositioner och foerfaranden foer smoerjning av metalldelar.
FI902686A0 (fi) Foerfarande foer framstaellning av dubbelsidigt belagda bandtransportoerer, i synnerhet foer pappers- och textilmaskiner, och anordning foer utfoering av foerfarandet.
FI900682A0 (fi) Verktyg, paosaettningsmedel och ringanordning foer kedjor foer foerhindrande av glidning.
FI905929A0 (fi) Anordning foer att oeverfoera skaerl, saosom flaskor, burkkar och dylika.
FI901461A0 (fi) Underrede foer raelsfoerbundna godsvagn, saerskilt foer tankvagnar och kapslade bulkgodsvagnar.
FI903630A0 (fi) Fluoranfoereningar, deras kristallina toluenaddukter, dessa innehaollande upptagningsmaterial och foerfarande foer deras framstaellning.
FI905753A0 (fi) Biologiskt nedbrytbara, vattenloesliga polykarboxylsyrakopolymerer, kompositioner innehaollande dylika kopolymerer, och foerfaranden foer anvaendning av saodana polymerer.
FI891891A0 (fi) Aminosyraestrar, foerfarande foer deras framstaellning, dessa innehaollande laekemedel och deras anvaendning.
FI901958A0 (fi) Reninhaemmande dipeptider, foerfarande foer deras framstaellning, dessa innehaollande aemnen och deras anvaendning.
FI904656A0 (fi) Fluoranfoereningar, foerfarande foer deras framstaellning och naemnda foerening innehaollande upptagningsmaterial.
FI922370L (fi) Staoltraod foer foerstaerkning av en inbaeddningsblandning, saerskilt betong och foerfarande foer framstaellning av en saodan.

Legal Events

Date Code Title Description
FD Application lapsed
FD Application lapsed

Owner name: FUJISAWA PHARMACEUTICAL CO., LTD.